Skip to content
2000
Volume 31, Issue 26
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Background

Polycystic ovarian syndrome (PCOS) is a hormonal disorder caused by excessive secretion of male sex hormones in females. Herbal remedies for PCOS are lightning up as they bypass the adverse effects and are profoundly safe on prolonged usage.

Objective

The present study included a selection of 34 herbs pursuing biological effects on the uterus, and their major chemical constituents were subjected to a series of techniques using different software. The proteins contributing majorly to the hormonal functions like human cytochrome P450 CYP17A1 (3RUK), progesterone (1E3K), and estrogen receptor (1X7R) were selected for the study.

Methods

Molecular docking studies were performed using AutoDock 1.5.7. The pharmacokinetic properties were predicted using the SwissADME online tool, while toxicity parameters were assessed with OSIRIS toxicity explorer and pkCSM. Molecular dynamics simulations and free energy calculations were performed using the Schrödinger suite.

Results

Constituents with a basic steroidal nucleus demonstrated high binding energy values. An analysis of all the techniques showed that Sarsasapogenin from exhibited strong binding energies of -10.88 kcal/mol, -10.51 kcal/mol, and -9.79 kcal/mol with the selected specific proteins. In molecular dynamics simulations, Sarsasapogenin displayed ideal stability, with RMSD fluctuations below 3 Å and RMSF slightly higher than the corresponding peak of apoprotein. Additionally, it showed a favorable drug-likeness profile and non-toxic effects across all screened parameters.

Conclusion

From the list of the selected constituents, Sarsasapogenin was found to be ideal, and further research on it for targeting PCOS is expected to yield promising results.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cpd/10.2174/0113816128330398241015115043
2024-11-07
2025-09-02

  • From This Site

    /content/journals/cpd/10.2174/0113816128330398241015115043
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. MarchW.A. MooreV.M. WillsonK.J. PhillipsD.I.W. NormanR.J. DaviesM.J. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.Hum. Reprod.201025254455110.1093/humrep/dep39919910321
     [Google Scholar]
  2. CooperH.E. SpellacyW.N. PremK.A. CohenW.D. Hereditary factors in the Stein-Leventhal syndrome.Am. J. Obstet. Gynecol.1968100337138710.1016/S0002‑9378(15)33704‑215782458
     [Google Scholar]
  3. KabelA.M. Polycystic ovarian syndrome: Insights into pathogenesis, diagnosis, prognosis, pharmacological and non-pharmacological treatment.Pharm. Bioprocess.201641712
     [Google Scholar]
  4. GadeR. DwarampudiL.P. DharshiniS.P. RajR.K. Polycystic ovarian syndrome (PCOS): Approach to traditional systems, natural and bio-chemical compounds for its management.Indian J. Biochem. Biophys.2022595521527
     [Google Scholar]
  5. LimS.S. HutchisonS.K. Van RyswykE. NormanR.J. TeedeH.J. MoranL.J. Lifestyle changes in women with polycystic ovary syndrome.Cochrane Libr.201920193CD00750610.1002/14651858.CD007506.pub430921477
     [Google Scholar]
  6. TayC.T. HartR.J. HickeyM. MoranL.J. EarnestA. DohertyD.A. TeedeH.J. JohamA.E. Updated adolescent diagnostic criteria for polycystic ovary syndrome: Impact on prevalence and longitudinal body mass index trajectories from birth to adulthood.BMC Med.202018138910.1186/s12916‑020‑01861‑x33302955
     [Google Scholar]
  7. JonesG.L. Palep-SinghM. LedgerW.L. BalenA.H. JenkinsonC. CampbellM.J. LashenH. Do South Asian women with PCOS have poorer health-related quality of life than Caucasian women with PCOS? A comparative cross-sectional study.Health Qual. Life Outcomes20108114910.1186/1477‑7525‑8‑14921171983
     [Google Scholar]
  8. MooreA.M. CampbellR.E. Polycystic ovary syndrome: Understanding the role of the brain.Front. Neuroendocrinol.20174611410.1016/j.yfrne.2017.05.00228551304
     [Google Scholar]
  9. VassilatouE. Nonalcoholic fatty liver disease and polycystic ovary syndrome.World J. Gastroenterol.201420268351836310.3748/wjg.v20.i26.835125024594
     [Google Scholar]
  10. CakirE. SahinM. TopalogluO. ColakN. KarbekB. GungunesA. ArslanM. UnsalI. TutalE. UcanB. DelibasiT. The relationship between LH and thyroid volume in patients with PCOS.J. Ovarian Res.2012514310.1186/1757‑2215‑5‑4323231775
     [Google Scholar]
  11. BalkrishnaA. RanaM. MishraS. Incredible combination of lifestyle modification and herbal remedies for polycystic ovarian syndrome management.Evid. Based Compl. Altern. Med.2023202370550810.1155/2023/3705508
     [Google Scholar]
  12. LakshmiJ.N. BabuA.N. KiranS.S.M. NoriL.P. HassanN. AshamesA. BhandareR.R. ShaikA.B. Herbs as a source for the treatment of polycystic ovarian syndrome: A systematic review.BioTech2023121410.3390/biotech1201000436648830
     [Google Scholar]
  13. RaufA. AkramM. SemwalP. MujawahA.A.H. MuhammadN. RiazZ. MunirN. PiotrovskyD. VdovinaI. BouyahyaA. AdetunjiC.O. ShariatiM.A. AlmarhoonZ.M. MabkhotY.N. KhanH. Antispasmodic potential of medicinal plants: A comprehensive review.Oxid. Med. Cell. Longev.202120211488971910.1155/2021/488971934804367
     [Google Scholar]
  14. WangY. FuX. XuJ. WangQ. KuangH. Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome.Sci. Rep.201662808910.1038/srep28089
     [Google Scholar]
  15. MalekiV. FaghfouriA.H. TabriziF.P.F. MoludiJ. Saleh-GhadimiS. Jafari-VayghanH. QaisarS.A. Mechanistic and therapeutic insight into the effects of cinnamon in polycystic ovary syndrome: a systematic review.J. Ovarian Res.202114113010.1186/s13048‑021‑00870‑534627352
     [Google Scholar]
  16. KalachaveeduM. RaghavanD. TelapoluS. KuruvillaS. KedikeB. Phytoestrogenic effect of Inula racemosa Hook f – A cardioprotective root drug in traditional medicine.J. Ethnopharmacol.201821040841610.1016/j.jep.2017.09.00128893570
     [Google Scholar]
  17. MutrejaA. AgarwalM. KushwahaS. ChauhanA. Effect of Nelumbo nucifera seeds on the reproductive organs of female rats.Iran. J. Reprod. Med.200861711
     [Google Scholar]
  18. ShuklaS. MathurR. PrakashA.O. Antifertility profile of the aqueous extract of Moringa oleifera roots.J. Ethnopharmacol.1988221516210.1016/0378‑8741(88)90230‑93352285
     [Google Scholar]
  19. SharmaS. SharmaA.K. Female anti-fertility screening of plants Mucuna prurita, Mesua ferrea and Punica granatum on rats.Int J Pharm Chem Res.201733697699
     [Google Scholar]
  20. KhannaA. ThomasJ. JohnF. MaliakelB. KrishnakumarI.M. Safety and influence of a novel extract of fenugreek on healthy young women: A randomized, double-blinded, placebo-controlled study.Clin. Phytosci.2021716310.1186/s40816‑021‑00296‑y
     [Google Scholar]
  21. AtashpourS. Kargar JahromiH. Kargar JahromiZ. MaleknasabM. Comparison of the effects of Ginger extract with clomiphene citrate on sex hormones in rats with polycystic ovarian syndrome.Int. J. Reprod. Biomed. (Yazd)201715956156810.29252/ijrm.15.9.56129662964
     [Google Scholar]
  22. SheejaE. JoshiS.B. JainD.C. Antiovulatory and estrogenic activity of Plumbago rosea leaves in female albino rats.Indian J. Pharmacol.200941627327710.4103/0253‑7613.5992720407559
     [Google Scholar]
  23. NjogaU.J. JajaI.F. OnwukaO.S. IloS.U. EkeI.G. AbahK.O. OguejioforC.F. OchioguI.S. Reproductive effects of medicinal plant (Azadirachta indica) used as forage and for ethnoveterinary practices: New insights from animal models.Challenges20221324010.3390/challe13020040
     [Google Scholar]
  24. Nasimi Doost AzgomiR. ZomorrodiA. NazemyiehH. FazljouS.M.B. Sadeghi BazarganiH. NejatbakhshF. Moini JazaniA. Ahmadi AsrBadrY. Effects of Withania somnifera on reproductive system: A systematic review of the available evidence.BioMed Res. Int.2018201811710.1155/2018/407643029670898
     [Google Scholar]
  25. SirotkinA.V. KolesárováA. Puncture vine (Tribulus Terrestris L.) in control of health and reproduction.Physiol. Res.202170Suppl. 4S657S66710.33549/physiolres.93471135199550
     [Google Scholar]
  26. PaulA.K. JahanR. PaulA. MahboobT. BondhonT.A. JannatK. The role of medicinal and aromatic plants against obesity and arthritis: A review.Nutrients202214598510.3390/nu14050985
     [Google Scholar]
  27. Dayani SiriwardeneS.A. KarunathilakaL.P.A. KodituwakkuN.D. KarunarathneY.A.U.D. Clinical efficacy of Ayurveda treatment regimen on Subfertility with poly cystic ovarian syndrome (PCOS).Ayu2010311242710.4103/0974‑8520.6820322131680
     [Google Scholar]
  28. Lilaram RaichurN.A. Abortifacient potential of ethanolic seed extract of Caesalpinia bonducella in female albino rats.J. Basic Clin. Physiol. Pharmacol.201425444545110.1515/jbcpp‑2013‑0120
     [Google Scholar]
  29. HekmatzadehS.F. BazarganipourF. MalekzadehJ. GoodarziF. ArameshS. A randomized clinical trial of the efficacy of applying a simple protocol of boiled Anethum graveolens seeds on pain intensity and duration of labor stages.Complement. Ther. Med.201422697097610.1016/j.ctim.2014.10.00725453516
     [Google Scholar]
  30. RasheedN. AhmedA. NosheenF. ImranA. IslamF. NoreenR. ChauhanA. ShahM.A. Amer AliY. Effectiveness of combined seeds (pumpkin, sunflower, sesame, flaxseed): As adjacent therapy to treat polycystic ovary syndrome in females.Food Sci. Nutr.20231163385339310.1002/fsn3.332837324929
     [Google Scholar]
  31. ThakorA.P. PatelA.J. Normalizing of estrous cycle in polycystic ovary syndrome (PCOS) induced rats with Tephrosia purpurea (Linn.) Pers.J. Appl. Nat. Sci.20146119720110.31018/jans.v6i1.400
     [Google Scholar]
  32. RaoB.B. MetriB.K. RaoB.S. NagaratnaR. Improvement in biochemical and psychopathologies in women having PCOS through yoga combined with herbal detoxification.J. Stem Cells2018134213222
     [Google Scholar]
  33. KhaniS. AbdollahiM. KhalajA. HeidariH. ZohaliS. The effect of hydroalcoholic extract of Nigella sativa seed on dehydroepiandrosterone-induced polycystic ovarian syndrome in rats: An experimental study.Int. J. Reprod. Biomed. (Yazd)202119327128210.18502/ijrm.v19i3.857533842824
     [Google Scholar]
  34. SayagoC. CamargoV. BarbosaF. GularteC. PereiraG. MiottoS. Cechinel FilhoV. Luiz PuntelR. FolmerV. MendezA. Chemical composition and in vitro antioxidant activity of hydro-ethanolic extracts from Bauhinia forficata subsp. pruinosa and B. variegata.Acta Biol. Hung.2013641213310.1556/ABiol.64.2013.1.323567828
     [Google Scholar]
  35. ChandranA. MerlinN.J. AmmuL. DharanS.S. Fennel treatment to PCOS: An in silico evaluation to explore the therapeutic efficacy of anethole.Res. J. Pharm. Technol.201912104958496210.5958/0974‑360X.2019.00860.6
     [Google Scholar]
  36. IonescuO.M. FrincuF. MehedintuA. PlotogeaM. CirstoiuM. PetcaA. VarlasV. MehedintuC. Berberine—a promising therapeutic approach to polycystic ovary syndrome in infertile/pregnant women.Life (Basel)202313112510.3390/life1301012536676074
     [Google Scholar]
  37. KandasamyV. BalasundaramU. Caesalpinia bonduc (L.) Roxb. as a promising source of pharmacological compounds to treat Poly Cystic Ovary Syndrome (PCOS): A review.J. Ethnopharmacol.202127911437510.1016/j.jep.2021.11437534192600
     [Google Scholar]
  38. MaityM. PerveenH. DashM. JanaS. KhatunS. DeyA. MandalA.K. ChattopadhyayS. Arjunolic acid improves the serum level of vitamin B12 and folate in the process of the attenuation of arsenic induced uterine oxidative stress.Biol. Trace Elem. Res.20181821789010.1007/s12011‑017‑1077‑028660490
     [Google Scholar]
  39. JadhavM. MenonS. ShailajanS. Anti-androgenic effect of Symplocos racemosa Roxb. against letrozole induced polycystic ovary using rat model.J. Coast. Life Med.201314309314
     [Google Scholar]
  40. FongodA.G.N. VeransoM.C. LibalahM.N. Identification and use of plants in treating infertility in human females in fako division, cameroon.Glob. J. Res. Med. Plants Indig. Med.2013211724737
     [Google Scholar]
  41. RaniR. ChitmeH.R. KukretiN. PantP. Abdel-WahabB.A. KhateebM.M. Regulation of insulin resistance, lipid profile and glucose metabolism associated with polycystic ovary syndrome by Tinospora cordifolia .Nutrients.202315102238
     [Google Scholar]
  42. ChoudharyN. ChoudharyS. KumarA. SinghV. Deciphering the multi-scale mechanisms of Tephrosia purpurea against polycystic ovarian syndrome (PCOS) and its major psychiatric comorbidities: Studies from network pharmacological perspective.Gene202177314538510.1016/j.gene.2020.14538533383117
     [Google Scholar]
  43. BalamuruganK. KalaichelvanV.K. SavkarT.A. Effect of methanolic extract of Saccharum officinarum on the biochemical milieu and histopathological profile of female albino rats.Biosci. Biotechnol. Res. Asia201071301306
     [Google Scholar]
  44. OngtanasupT. PrommeeN. JampaO. The cholesterol-modulating effect of the new herbal medicinal recipe from yellow vine (Coscinium fenestratum (Goetgh.)), Ginger (Zingiber officinale Roscoe.), and safflower (Carthamus tinctorius L.) on suppressing PCSK9 expression to upregulate LDLR expression in HepG2 cells.Plants.202211141835
     [Google Scholar]
  45. JivrajaniM. RavatN. AnandjiwalaS. NivsarkarM. Antiestrogenic and anti-inflammatory potential of n-hexane fraction of Vitex negundo Linn leaf extract: A probable mechanism for blastocyst implantation failure in Mus musculus. Int. Sch. Res. Notices201420141810.1155/2014/24194627351007
     [Google Scholar]
  46. MangathayaruK. SarahK. BalakrishnaK. Estrogenic effect of Erythrina variegata L. in prepubertal female rats.Indian J. Nat. Prod. Resour.201453223227
     [Google Scholar]
  47. DhimanK. Ayurvedic intervention in the management of uterine fibroids: A case series.Ayu201435330330810.4103/0974‑8520.15375026664240
     [Google Scholar]
  48. HussainS.P. RaoA.R. Chemopreventive action of mace (Myristica fragrans, Houtt) on methylcholanthrene-induced carcinogenesis in the uterine cervix in mice.Cancer Lett.199156323123410.1016/0304‑3835(91)90007‑52021927
     [Google Scholar]
  49. DarM.I. RafatS. DevK. Heartwood extract of Pterocarpus marsupium Roxb. offers defense against oxyradicals and improves glucose uptake in HepG2 cells.Metabolites.20221210947
     [Google Scholar]
  50. Al-SnafiP.D.A.E. Pharmacology of Ficus religiosa- A review.IOSR J. Pharm.201773496010.9790/3013‑0703014960
     [Google Scholar]
  51. MiddelkoopT.B. LabadieR.P. An in vitro examination of bark extracts from Saraca asoca (Roxb.) de Wilde and Rhododendron Arboreum Sm. for oxytocic activity.Int. J. Crude Drug Res.1986241414410.3109/13880208609060885
     [Google Scholar]
  52. GuptaA.K. Neeraj TandonM.S. Quality standards of Indian Medicinal Plants.In: Medicinal Plants Unit.New DelhiICMR2008
     [Google Scholar]
  53. CousinsK.R. Computer review of ChemDraw ultra 12.0.ACS Publications2011
     [Google Scholar]
  54. KambojA. VermaD. SharmaD. PantK. PantB. KumarV. A molecular docking study towards finding herbal treatment against Polycystic Ovary Syndrome (PCOS).Int. J. Recent. Technol. Eng.202082S123841
     [Google Scholar]
  55. SakhtemanA. PasdaranA. AfifiM. HamediA. An assay on the possible effect of essential oil constituents on receptors involved in women’s hormonal health and reproductive system diseases.J. Evid. Based Integr. Med.2020252515690X209325210.1177/2515690X20932527
     [Google Scholar]
  56. AlbiniA. RosanoC. AngeliniG. AmaroA. EspositoA.I. MaramottiS. NoonanD.M. PfefferU. Exogenous hormonal regulation in breast cancer cells by phytoestrogens and endocrine disruptors.Curr. Med. Chem.20142191129114510.2174/092986732166613112912464024304271
     [Google Scholar]
  57. YangL. LiuY. SternbergC. MolinS. Evaluation of enoyl-acyl carrier protein reductase inhibitors as Pseudomonas aeruginosa quorum-quenching reagents.Molecules201015278079210.3390/molecules1502078020335945
     [Google Scholar]
  58. MokaM.K. Computational investigation of four isoquinoline alkaloids against polycystic ovarian syndrome.J. Biomol. Struct. Dyn.202442273474610.1080/07391102.2023.222282837315995
     [Google Scholar]
  59. MorrisG.M. HueyR. OlsonA.J. Using autodock for ligand‐receptor docking.Curr. Protoc. Bioinforma.20082418.14.18.14.4010.1002/0471250953.bi0814s24
     [Google Scholar]
  60. HossainM.A. SharfarazA. HasanM.I. Molecular docking and pharmacology study to explore bio-active compounds and underlying mechanisms of Caesalpinia bonducella on polycystic ovarian syndrome.Informatics Med. Unlocked.202233101073
     [Google Scholar]
  61. SeeligerD. de GrootB.L. Ligand docking and binding site analysis with PyMOL and AutoDock/Vina.J. Comput. Aided Mol. Des.201024541742210.1007/s10822‑010‑9352‑620401516
     [Google Scholar]
  62. BibiS. HasanM.M. WangY.B. PapadakosS.P. YuH. Cordycepin as a promising inhibitor of SARS-CoV-2 RNA dependent RNA polymerase (RdRp).Curr. Med. Chem.202229115216210.2174/1875533XMTE3xNDEq034420502
     [Google Scholar]
  63. JejurikarB.L. RohaneS.H. Drug designing in discovery studio.Asian J. Res. Chem.2021142135138
     [Google Scholar]
  64. ShahV. BhaliyaJ. PatelG.M. In silico docking and ADME study of deketene curcumin derivatives (DKC) as an aromatase inhibitor or antagonist to the estrogen-alpha positive receptor (Erα+): Potent application of breast cancer.Struct. Chem.202233257160010.1007/s11224‑021‑01871‑235106036
     [Google Scholar]
  65. DuanL. JinD. AnX. ZhangY. ZhaoS. ZhouR. DuanY. ZhangY. LiuX. LianF. The potential effect of Rhizoma coptidis on polycystic ovary syndrome based on network pharmacology and molecular docking.Evid. Based Complement. Alternat. Med.2021202111210.1155/2021/557761034306142
     [Google Scholar]
  66. DainaA. MichielinO. ZoeteV. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules.Sci. Rep.2017714271710.1038/srep42717
     [Google Scholar]
  67. DeyD. BiswasP. PaulP. MahmudS. EmaT.I. KhanA.A. AhmedS.Z. HasanM.M. SaikatA.S.M. FatemaB. BibiS. RahmanM.A. KimB. Natural flavonoids effectively block the CD81 receptor of hepatocytes and inhibit HCV infection: A computational drug development approach.Mol. Divers.20232731309132210.1007/s11030‑022‑10491‑935821161
     [Google Scholar]
  68. KhanT. LawrenceA.J. AzadI. RazaS. JoshiS. KhanA.R. Computational drug designing and prediction of important parameters using in silico methods-A review.Curr. Computeraided Drug Des.201915538439710.2174/157339981566619032612000630914032
     [Google Scholar]
  69. DeyD. HossainR. BiswasP. PaulP. IslamM.A. EmaT.I. GainB.K. HasanM.M. BibiS. IslamM.T. RahmanM.A. KimB. Amentoflavone derivatives significantly act towards the main protease (3CLPRO/MPRO) of SARS-CoV-2: In silico admet profiling, molecular docking, molecular dynamics simulation, network pharmacology.Mol. Divers.202327285787110.1007/s11030‑022‑10459‑935639226
     [Google Scholar]
  70. BibiS. KhanM.S. El-KafrawyS.A. AlandijanyT.A. El-DalyM.M. YousafiQ. FatimaD. FaizoA.A. BajraiL.H. AzharE.I. Virtual screening and molecular dynamics simulation analysis of Forsythoside A as a plant-derived inhibitor of SARS-CoV-2 3CLpro.Saudi Pharm. J.2022307979100210.1016/j.jsps.2022.05.00335637849
     [Google Scholar]
  71. KathiravanM.K. SaravananV. NarayananP.L. SumathiD.L. KathiravanM.K. Molecular modelling investigation on 4-aminoquinoline derivatives as potent anti-tubercular agents.Journal of medical pharmaceutical and allied sciences20221155304531110.55522/jmpas.V11I5.4167
     [Google Scholar]
  72. ChowE. RendlemanC.A. BowersK.J. Desmond performance on a cluster of multicore processors.Simulation20081114
     [Google Scholar]
  73. SaravananV. ChagaletiB.K. PackiapalavesamS.D. KathiravanM. Ligand based pharmacophore modelling and integrated computational approaches in the quest for small molecule inhibitors against hCA IX.RSC Advances20241453346335810.1039/D3RA08618F38259989
     [Google Scholar]
  74. SchrödingerL.L.C. Schrödinger Release 2022-3: LigPrep.NY, USASchrödinger Inc New York2021
     [Google Scholar]
  75. PatelK.B. PatelR.V. AhmadI. RajaniD. PatelH. MukherjeeS. KumariP. Design, synthesis, molecular docking, molecular dynamic simulation, and MMGBSA analysis of 7-O-substituted 5-hydroxy flavone derivatives.J. Biomol. Struct. Dyn.202442126378639210.1080/07391102.2023.224352037551031
     [Google Scholar]
/content/journals/cpd/10.2174/0113816128330398241015115043
Loading
Screening of Optimal Phytoconstituents through In silico Docking, Toxicity, Pharmacokinetic, and Molecular Dynamics Approach for Fighting against Polycystic Ovarian Syndrome
Curr. Pharm. Des. 31, 2085 (2025); https://doi.org/10.2174/0113816128330398241015115043
/content/journals/cpd/10.2174/0113816128330398241015115043
/content/journals/cpd/10.2174/0113816128330398241015115043
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Research Article
Keyword(s): Asparagus racemosus; hormonal disorder; molecular docking; pharmacokinetic analysis; polycystic ovarian syndrome; Sarsasapogenin

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test